Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood Test

Completed

Conditions studied: Rheumatoid Arthritis

In brief

Nine months multi-center prospective, randomized observational study, two arm trial to evaluate the effect of MBDA score-guided care on disease activity and medical costs.

Key facts

Study ID
NCT03810144
Run by
Sequenom, Inc.
People needed
444
Starts
2018-10-22
Expected to finish
2022-10-16
Last updated by the study team
2023-08-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.